Baird Financial Group, Inc. Glaukos Corp Transaction History
Baird Financial Group, Inc.
- $50.2 Billion
- Q3 2024
A detailed history of Baird Financial Group, Inc. transactions in Glaukos Corp stock. As of the latest transaction made, Baird Financial Group, Inc. holds 75,535 shares of GKOS stock, worth $10.5 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
75,535
Previous 77,309
2.29%
Holding current value
$10.5 Million
Previous $9.15 Million
7.55%
% of portfolio
0.02%
Previous 0.02%
Shares
27 transactions
Others Institutions Holding GKOS
# of Institutions
340Shares Held
47.1MCall Options Held
132KPut Options Held
188K-
Black Rock Inc. New York, NY8.04MShares$1.11 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.87MShares$813 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.18MShares$302 Million0.05% of portfolio
-
State Street Corp Boston, MA1.95MShares$271 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.64MShares$227 Million0.06% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $6.59B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...